Rodger Tiedemann

6PUBLICATIONS
40CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyMedical infection agents (incl. prions)Gene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 30, 2026
Forimtamig, a GPRC5DxCD3 bispecific antibody with a novel 2:1 format, in relapsed/refractory multiple myeloma.

|Sep 16, 2026
Identification of broadly tumour-reactive γδ TCRs from multiple myeloma.

|Nov 05, 2025
PIKfyve inhibition in MM disrupts autophagy and lysosome function, increasing MHC expression and cholesterol metabolism.

Cecilia Bonolo de Campos, Ruijuan He, Tessa Pelino

|Jan 13, 2023
Single-cell profiling of multiple myeloma reveals molecular response to FGFR3 inhibitor despite clinical progression.

Danielle C Croucher, Anup Joseph Devasia, Dor D Abelman

|Jun 25, 2021
Combined EZH2 Inhibition and IKAROS Degradation Leads to Enhanced Antitumor Activity in Diffuse Large B-cell Lymphoma.

Kit I Tong, Sharon Yoon, Keren Isaev

|Sep 19, 2019
Chromosomal Instability and mTORC1 Activation through PTEN Loss Contribute to Proteotoxic Stress in Ovarian Carcinoma.

M Herman Chui, Sasha A Doodnauth, Natalie Erdmann

Pageof 1

Frequent Collaborators

2 joint publications

Dor David Abelman

2 joint publications

Michael St Paul

2 joint publications

Trevor Pugh

2 joint publications

Suzanne Trudel